ACRO BIOMEDICAL CO., LTD. (ACBM)
About ACRO BIOMEDICAL CO., LTD.
ARCO BIOMEDICAL CO LTD
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$101.1K
- Total assets
- $14.1K
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Acro Biomedical Co., Ltd. (ACBM) Stock Price
- Reported a net loss of $101.1K in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ACRO BIOMEDICAL CO., LTD..
Write a review
Acro Biomedical Co., Ltd.: frequently asked questions
Is Acro Biomedical Co., Ltd. an American company?
Acro Biomedical Co., Ltd. is a US-based company headquartered in Fishers, Indiana, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Acro Biomedical Co., Ltd. headquartered?
Acro Biomedical Co., Ltd. is headquartered in Fishers, Indiana, United States.
Is Acro Biomedical Co., Ltd. publicly traded?
Yes — Acro Biomedical Co., Ltd. is a publicly traded company. Its stock trades under the ticker symbol ACBM on the OTC.
